Browse > Article
http://dx.doi.org/10.5397/CiSE.2012.15.2.65

Differential Potential of Stem Cells Following Their Origin - Subacromial Bursa, Bone Marrow, Umbilical Cord Blood -  

Sim, Sung Woo (Departments of Orthopedics, Chosun University Hospital)
Moon, Young Lae (Departments of Orthopedics, Chosun University Hospital)
Kang, Jung Hun (Departments of Orthopedics, Chosun University Hospital)
Publication Information
Clinics in Shoulder and Elbow / v.15, no.2, 2012 , pp. 65-72 More about this Journal
Abstract
Purpose: To evaluate the differentiation potential of stem cells and their immunophenotype from 3 different sources. Methods: Our study involved three stem cell sources-subacromial bursal tissue, bone marrow, and umbilical cord blood. We obtained the subacromial bursal tissue and bone marrow from the patients undergoing shoulder surgery. After collecting the sample, we applied specific induction media for neurogenic, adipogenic and osteogenic differentiation. Also, flow-cytometry analysis was done to reveal the cell surface antigens. Results: We obtained 100% (8 cases) neural and adipogenic differentiation, but 62.5% (5 of 8 cases) osseous differentiation among the subacromial bursal tissue group. Bone marrow derived cells showed 100% neural (6 cases) and adipogenic (5 cases) differentiation, but 80% (4 of 5 cases) osseous differentiation. Umbilical cord blood derived cells revealed 97% (65 of 67 cases) neural, 53.7% (29 of 54 cases) adipogenic and 68.4% (39 of 57 cases) osseous differentiation. Immunophenotype analysis revealed that surface markers of bone marrow, subacromial bursal cell and umbilical cord blood derived mesenchymal stem cells are different from each other. Conclusions: Mesenchymal stem cells are potential agents in regenerative medicine and are characterized by expression of surface markers and by their differentiation potential. Our study with stem cells from subacromial bursal tissue, bone marrow and umbilical cord discovered that each stem cell has unique differentiation potential and function based on its origin. Various stem cells show multi-lineage differentiations in vitro which can be correlated to in vivo conditions.
Keywords
Differentiation potential; Mesenchymal stem cell; Umbilical Cord blood; Bone marrow; Subacromial bursal cell;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36:568-84.   DOI   ScienceOn
2 Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-7.   DOI   ScienceOn
3 Yang SE, Ha CW, Jung M, et al. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy. 2004;6:476-86.   DOI   ScienceOn
4 Niibe K, Kawamura Y, Araki D, et al. Purified mesenchymal stem cells are an efficient source for iPS cell induction. PLoS One. 2011;6:e17610.   DOI   ScienceOn
5 Peyrard T, Bardiaux L, Krause C, et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev. 2011;25:206-16.   DOI   ScienceOn
6 Satomura K, Krebsbach P, Bianco P, Gehron Robey P. Osteogenic imprinting upstream of marrow stromal cell differentiation. J Cell Biochem. 2000;78:391-403.   DOI   ScienceOn
7 Shafiee A, Kabiri M, Ahmadbeigi N, et al. Nasal Septum-Derived Multipotent Progenitors: A Potent Source for Stem Cell-Based Regenerative Medicine. Stem Cells Dev. 2011;20:2077-91.   DOI   ScienceOn
8 Ratajczak MZ, Zuba-Surma EK, Machalinski B, Kucia M. Bone-marrow-derived stem cells--our key to longevity?. J Appl Genet. 2007;48:307-19.   DOI   ScienceOn
9 Reyes M, Verfaillie CM. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci. 2001;938:231-3. discussion 3-5.
10 Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells. 2007;25:2066-73.   DOI   ScienceOn
11 Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294-301.   DOI   ScienceOn
12 Uhthoff HK, Trudel G, Himori K. Relevance of pathology and basic research to the surgeon treating rotator cuff disease. J Orthop Sci. 2003;8:449-56.   DOI
13 Moon YL, Song CH, Noh KH, Lee SJ, Lee HJ, Kim SH. Isolation and Phenotypic Characterization of Multipotent Mesenchymal-like Stem Cells from Human Subacromial Bursa. J Tissue Eng Regen Med. 2009;5:527-32.
14 Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7.   DOI   ScienceOn
15 Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica. 2001;86:1099-100.